Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -1.94% is 81% above its 5-year average of -10.08%, near the high end of its 5-year range (-24.57%–2.76%).
26.15% above its 12-month average of -2.63%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-07-04): -5.31%.
EBITDA MARGIN
-1.94%
EBITDA MARGIN AVG TTM
-2.63%
EBITDA MARGIN AVG 3Y
-8.28%
EBITDA MARGIN AVG 5Y
-10.08%
EBITDA MARGIN AVG 10Y
-14.87%
EBITDA MARGIN AVG 15Y
-8.84%
EBITDA MARGIN AVG 20Y
-7.16%
CURRENT VS TTM AVG
+26.15%
CURRENT VS 3Y AVG
+76.57%
CURRENT VS 5Y AVG
+80.75%
CURRENT VS 10Y AVG
+86.96%
CURRENT VS 15Y AVG
+78.07%
CURRENT VS 20Y AVG
+72.89%
IRIDEX Corporation
Market Cap
$12.41M
EBITDA Margin
-1.94%
TTM Avg
-2.63%
3Y Avg
-8.28%
5Y Avg
-10.08%
Market Cap
$12.61M
EBITDA Margin
-1106.68%
TTM Avg
-120183.14%
3Y Avg
-60445.11%
5Y Avg
-60445.11%
Market Cap
$13.34M
EBITDA Margin
-16245.70%
TTM Avg
-13416.38%
3Y Avg
-13330.05%
5Y Avg
-20098.17%
Market Cap
$12.00M
EBITDA Margin
-34.02%
TTM Avg
-37.67%
3Y Avg
-64.98%
5Y Avg
-56.41%
Market Cap
$11.82M
EBITDA Margin
-5650.91%
TTM Avg
-5650.91%
3Y Avg
-12817.85%
5Y Avg
-12817.85%
Market Cap
$13.83M
EBITDA Margin
-855.47%
TTM Avg
-475.86%
3Y Avg
-335.10%
5Y Avg
-307.83%
Market Cap
$11.17M
EBITDA Margin
28.31%
TTM Avg
28.31%
3Y Avg
28.31%
5Y Avg
-18969.31%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IRIDEX Corporation (IRIX) | $12.41M | -1.94% | -2.63% | -8.28% | -10.08% |
| Dare Bioscience, Inc. (DARE)vs › | $12.61M | -1106.68% | -120183.14% | -60445.11% | -60445.11% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.34M | -16245.70% | -13416.38% | -13330.05% | -20098.17% |
| Lantern Pharma Inc. (LTRN)vs › | $11.87M | N/A | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.00M | -34.02% | -37.67% | -64.98% | -56.41% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.74M | N/A | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.82M | -5650.91% | -5650.91% | -12817.85% | -12817.85% |
| Vyome Holdings, Inc. (HIND)vs › | $13.83M | -855.47% | -475.86% | -335.10% | -307.83% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.17M | 28.31% | 28.31% | 28.31% | -18969.31% |
| IN8bio, Inc. (INAB)vs › | $13.62M | N/A | N/A | N/A | N/A |
Gross Margin
36.2%
EBITDA Margin
-1.9%
Operating Margin
-5.4%
Net Margin
-6.9%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-07-04 | -5.31% |
| 2026-04-04 | 0.41% |
| 2026-01-03 | 2.76% |
| 2025-09-27 | -8.37% |
| 2025-06-28 | -4.14% |
| 2025-03-29 | 1.48% |
| 2024-12-31 | -0.98% |
| 2024-09-28 | -13.77% |
| 2024-06-29 | -17.96% |
| 2024-03-30 | -24.57% |
| 2023-12-31 | -18.50% |
| 2023-09-30 | -10.37% |
| 2023-07-01 | -18.51% |
| 2023-04-01 | -14.29% |
| 2022-12-31 | -2.40% |
| 2022-10-01 | -9.09% |
| 2022-07-02 | -12.91% |
| 2022-04-02 | -16.12% |
| 2021-12-31 | -14.30% |
| 2021-10-02 | -14.59% |
| 2021-07-03 | -6.80% |
| 2021-04-03 | -14.22% |
| 2020-12-31 | -1.58% |
| 2020-09-26 | -19.58% |
| 2020-06-27 | -42.61% |
| 2020-03-28 | -16.74% |
| 2019-12-31 | -12.30% |
| 2019-09-28 | -15.84% |
| 2019-06-29 | -22.30% |
| 2019-03-30 | -26.66% |
| 2018-12-31 | -23.69% |
| 2018-09-29 | -25.07% |
| 2018-06-30 | -29.89% |
| 2018-03-31 | -36.01% |
| 2017-12-31 | -49.01% |
| 2017-09-30 | -26.03% |
| 2017-07-01 | -25.30% |
| 2017-04-01 | -15.75% |
| 2016-12-31 | -7.09% |
| 2016-10-01 | -11.00% |
| 2016-07-02 | -2.06% |
| 2016-04-02 | 2.46% |
| 2015-12-31 | 5.13% |
| 2015-10-03 | 2.85% |
| 2015-07-04 | -6.81% |
| 2015-04-04 | 4.84% |
| 2014-12-31 | 9.31% |
| 2014-09-27 | 7.02% |
| 2014-06-28 | 4.67% |
| 2014-03-29 | 6.83% |
| 2013-12-31 | 6.44% |
| 2013-09-28 | 8.28% |
| 2013-06-29 | 6.83% |
| 2013-03-30 | 11.44% |
| 2012-12-31 | 4.57% |
| 2012-09-29 | -5.99% |
| 2012-06-30 | -3.08% |
| 2012-03-31 | -1.48% |
| 2011-12-31 | 133.15% |
| 2011-10-01 | 5.74% |
| 2011-07-02 | 4.81% |
| 2011-04-02 | 6.52% |
| 2010-12-31 | 10.49% |
| 2010-10-02 | 9.38% |
| 2010-07-03 | 2.62% |
| 2010-04-03 | 7.02% |
| 2009-12-31 | 8.94% |
| 2009-10-03 | 11.30% |
| 2009-07-04 | 5.81% |
| 2009-04-04 | 5.56% |
| 2008-12-31 | -45.34% |
| 2008-09-27 | 4.32% |
| 2008-06-28 | 4.57% |
| 2008-03-29 | 0.74% |
| 2007-12-31 | -105.91% |
| 2007-09-29 | 1.64% |
| 2007-06-30 | -10.16% |
| 2007-03-31 | -31.77% |
| 2006-12-31 | -19.92% |
| 2006-09-30 | -14.63% |
| 2006-07-01 | -4.71% |
| 2006-04-01 | -6.48% |
| 2005-12-31 | 7.75% |
| 2005-10-01 | 8.96% |
| 2005-07-02 | 7.12% |
| 2005-04-02 | -0.55% |
| 2004-12-31 | 4.17% |
| 2004-10-02 | -16.24% |
| 2004-07-03 | 2.50% |
| 2004-04-03 | 0.70% |
| 2003-12-31 | 6.26% |
| 2003-09-27 | 4.58% |
| 2003-06-28 | -4.02% |
| 2003-03-29 | 0.36% |
| 2002-12-31 | 11.54% |
| 2002-09-28 | 3.13% |
